AI assistant
Medpace Holdings, Inc. — Director's Dealing 2023
Sep 20, 2023
30442_dirs_2023-09-20_19dcc2a4-76de-48c6-a866-4e421ad46565.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2023-09-18
Reporting Person: Medpace Investors, LLC (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-18 | Common Stock | S | 53385 | $274.76 | Disposed | 6179634 | Direct |
| 2023-09-19 | Common Stock | S | 137379 | $259.66 | Disposed | 6042255 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 1, 2023.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $271.505 to $278.665. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $254.74 to $271.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.